ARDS Clinical Trial
Official title:
Feasibility and Physiological Effects of a Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection
Verified date | August 2021 |
Source | Hospital Nacional Edgardo Rebagliati Martins |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to evaluate if a postural recruitment maneuver (PRM) improves the aeration and distribution of lung ventilation in patients with Acute Respiratory Distress Syndrome (ARDS) caused by COVID-19 infection; without the need to reach high airway pressures as in the standard lung recruitment maneuver and / or place the patient in prone position. This strategy could be particularly useful in the context of a major health emergency in centers with limited resources.
Status | Completed |
Enrollment | 15 |
Est. completion date | October 31, 2020 |
Est. primary completion date | September 30, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients > 18 years of age - Patients with moderate-to-severe ARDS as per the Berlin definition - Infection due to COVID-19 - Body mass index (BMI) = 35 kg /m^2. Exclusion Criteria: - Contraindication for EIT monitoring 1. Unstable spine or pelvic fractures 2. Pacemaker, automatic implantable cardioverter defibrillator 3. Skin lesions between the 4th and 5th ribs where the EIT belt is worn - Pregnancy - Major hemodynamic instability:: 1. Mean arterial pressure lower than 60 mm Hg despite adequate fluid resuscitation and use of vasopressors. 2. FC> 120 or <60 per minute 3. Presence of uncontrolled arrhythmias. - More than 1 week of mechanical ventilation - Failure of more than 2 extrapulmonary organs. |
Country | Name | City | State |
---|---|---|---|
Peru | Hospital Rebagliati | Jesús María | Lima |
Lead Sponsor | Collaborator |
---|---|
Hospital Nacional Edgardo Rebagliati Martins | Universidad de Piura |
Peru,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Effects of a postural recruitment maneuver in lung aeration | Lung aeration measured by ultrasound reaeration score, ranges from 0 (all regions are well aerated) to 36 (all regions are consolidated). | Through study completion (up to 24 hours) | |
Primary | Effects of a postural recruitment maneuver in distribution of ventilation | Distribution of ventilation measured by EIT (distribution and changes in the impedance in AU, arbitray units) | Through study completion (up to 24 hours) | |
Primary | Effects of a postural recruitment maneuver in gas exchange | Gas exchange measured by blood gas analysis (PaO2, PaCO2, in mmHg) and capnography (end-tidal CO2, in mmHg) | Through study completion (up to 24 hours) | |
Primary | Effects of a postural recruitment maneuver in respiratory mechanics | Respiratory mechanics measured by esophageal balloon (esophageal pressure, transpulmonary pressure, in cmH2O) | Through study completion (up to 24 hours) | |
Primary | Effects of a postural recruitment maneuver in hemodynamic | Hemodynamic data measured by invasive arterial monitoring (mean arterial pressure, in mmHg) | Through study completion (up to 24 hours) | |
Secondary | Feasibility of a postural recruitment maneuver | Oxigenatory tolerance evaluated with pulse oximeter (arterial oxygen saturation, in percentage) | Through study completion (up to 24 hours) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04435613 -
Clinical and Physiological Assessment of a Nearly Ultra-protective Lung Ventilation Strategy: A Quasi-experimental Preliminary Study in ARDS Patients
|
N/A | |
Enrolling by invitation |
NCT05020210 -
Effect of Early Treatment With Sivelestat Sodium in ARDS Patients
|
||
Completed |
NCT04468971 -
REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia
|
Phase 1 | |
Completed |
NCT04505592 -
Tenecteplase in Patients With COVID-19
|
Phase 2 | |
Completed |
NCT04493242 -
Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS
|
Phase 2 | |
Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
Completed |
NCT02265198 -
Relationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome
|
N/A | |
Completed |
NCT01949272 -
Optimization of PEEP for Alveolar Recruitment in ARDS
|
N/A | |
Not yet recruiting |
NCT01668368 -
Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance
|
N/A | |
Completed |
NCT01881061 -
Lung Sonography in Patients With Acute Respiratory Distress Syndrome in Intensive Care Unit
|
N/A | |
Completed |
NCT00808691 -
Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit
|
N/A | |
Completed |
NCT05035589 -
The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumonia
|
||
Recruiting |
NCT04764032 -
Right Ventricular Dysfunction in Ventilated Patients With COVID-19
|
||
Completed |
NCT04556513 -
Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status
|
||
Recruiting |
NCT06036056 -
NMR Based Metabolomics Kinetics in ARDS Patients
|
||
Recruiting |
NCT04503876 -
Effects of End-expiratory Positive Pressure Optimization in Intubated Patients With Healthy Lung or Acute Respiratory Distress Syndrome
|
N/A | |
Recruiting |
NCT04643691 -
Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS
|
Phase 2 | |
Completed |
NCT04395911 -
Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections
|
N/A | |
Not yet recruiting |
NCT05341687 -
Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.
|
||
Recruiting |
NCT05056090 -
Effect of Prone Positioning on Mortality in Patients With Mild to Moderate Acute Respiratory Distress Syndrome.
|
N/A |